Terms: = Kidney tumors AND ARID2, ENSG00000189079, 196528, Q68CP9, p200, KIAA1557, FLJ30619, DKFZp779P0222, DKFZp686G052, BAF200
5 results:
1. PBRM1-deficient PBAF complexes target aberrant genomic loci to activate the NF-κB pathway in clear cell renal cell carcinoma.
Yao X; Hong JH; Nargund AM; Ng MSW; Heng HL; Li Z; Guan P; Sugiura M; Chu PL; Wang LC; Ye X; Qu J; Kwek XY; Lim JCT; Ooi WF; Koh J; Wang Z; Pan YF; Ong YS; Tan KY; Goh JY; Ng SR; Pignata L; Huang D; Lezhava A; Tay ST; Lee M; Yeo XH; Tam WL; Rha SY; Li S; Guccione E; Futreal A; Tan J; Yeong JPS; Hong W; Yauch R; Chang KT; Sobota RM; Tan P; Teh BT
Nat Cell Biol; 2023 May; 25(5):765-777. PubMed ID: 37095322
[TBL] [Abstract] [Full Text] [Related]
2. Prevalence of SWI/SNF genomic alterations in cancer and association with the response to immune checkpoint inhibitors: A systematic review and meta-analysis.
Wang N; Qin Y; Du F; Wang X; Song C
Gene; 2022 Aug; 834():146638. PubMed ID: 35680019
[TBL] [Abstract] [Full Text] [Related]
3. Loss of PBRM1 Alters Promoter Histone Modifications and Activates ALDH1A1 to Drive Renal Cell Carcinoma.
Schoenfeld DA; Zhou R; Zairis S; Su W; Steinbach N; Mathur D; Bansal A; Zachem AL; Tavarez B; Hasson D; Bernstein E; Rabadan R; Parsons R
Mol Cancer Res; 2022 Aug; 20(8):1193-1207. PubMed ID: 35412614
[TBL] [Abstract] [Full Text] [Related]
4. Recurrent chromosomal gains and heterogeneous driver mutations characterise papillary renal cancer evolution.
Kovac M; Navas C; Horswell S; Salm M; Bardella C; Rowan A; Stares M; Castro-Giner F; Fisher R; de Bruin EC; Kovacova M; Gorman M; Makino S; Williams J; Jaeger E; Jones A; Howarth K; Larkin J; Pickering L; Gore M; Nicol DL; Hazell S; Stamp G; O'Brien T; Challacombe B; Matthews N; Phillimore B; Begum S; Rabinowitz A; Varela I; Chandra A; Horsfield C; Polson A; Tran M; Bhatt R; Terracciano L; Eppenberger-Castori S; Protheroe A; Maher E; El Bahrawy M; Fleming S; Ratcliffe P; Heinimann K; Swanton C; Tomlinson I
Nat Commun; 2015 Mar; 6():6336. PubMed ID: 25790038
[TBL] [Abstract] [Full Text] [Related]
5. Autoimmune blistering dermatoses as systemic diseases.
Vassileva S; Drenovska K; Manuelyan K
Clin Dermatol; 2014; 32(3):364-75. PubMed ID: 24767184
[TBL] [Abstract] [Full Text] [Related]
